MaaT Pharma

MaaT Pharma financial statements

MaaT Pharma's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueEUR 4.52MEODHD
Net income−EUR 31.06MEODHD
Cash and equivalentsEUR 24.87MEODHD
Total debtEUR 17.44MEODHD

MaaT Pharma financials on 6ix · MaaT Pharma on 6ix